Skip to main content
Top
Published in: Sleep and Breathing 2/2018

01-05-2018 | Sleep Breathing Physiology and Disorders • Original Article

Polysomnographic determinants of requirement for advanced positive pressure therapeutic options for obstructive sleep apnea

Published in: Sleep and Breathing | Issue 2/2018

Login to get access

Abstract

Background

A small percentage of adult patients with severe obstructive sleep apnea (OSA) has been recognized to be extraordinarily difficult to treat with conventional continuous or Bi-level positive airway pressure (together referred to as PAP) therapy.

Aim and objectives

The aim of this study was to determine polysomnographic (PSG) characteristics, which may help predict the requirement for advanced therapeutic options for OSA.

Methods

Consecutive patients who underwent PAP titration at our sleep laboratory over a 2-year period were included. Patients with technically inadequate studies, those with incomplete titration due to intolerance, mask-related problems, or lack of sleep and those with significant co-morbidity and with other primary sleep disorders, were excluded. The PSGs (diagnostic + titration parts) were categorized into three types: type A (respiratory events evenly distributed over all sleep stages), type B (REM dominant respiratory events), and type C (non-REM dominant respiratory events, mainly during cyclic alternating pattern [CAP] sleep). Group A was further subdivided into A1 (those whose hypnogram normalized after adequate titration) and A2 (those whose hypnogram converted to a type C pattern on titration). These were categorized again into treatment group I (adequately PAP titrated) and group II (poor response to conventional PAP) for studying factors determining poor response to PAP.

Results

Among 249 patients evaluated in the sleep laboratory over the study period, 123 (103 males, mean age 49.9 ± 10.8 years, mean BMI 29.3 ± 4) fulfilled inclusion criteria. These could be grouped as type A (n = 85), B (n = 33), and C (n = 5). On titration, 57 patients of type A and 21 of type B could be successfully titrated, while 24 in type A and 11 in type B, converted into type C. Therefore, in group II (n = 43), 38 patients fell in type C, overtly and after titration. Twelve of these had been successfully treated using adaptive servo ventilation (ASV) while another 28 could be treated using the Bi-level PAP-ST mode. The only PSG feature predicting poor response to conventional PAP was the presence of post-arousal central apnea (p = 0.001). The main difference between the A1 + B groups and A2 + C groups was the significantly higher non-REM apnea hypopnea index in the latter. Among these, on 1-year follow-up, eight patients were using Bi-level PAP-ST mode, while four patients were using ASV and were asymptomatic.

Conclusion

Non-REM sleep instability and the presence of post-arousal central apneas may be important determinants of poor response to conventional PAP and requirement for advanced therapeutic options among patients with severe OSA.
Literature
1.
go back to reference Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–1014CrossRefPubMedPubMedCentral Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–1014CrossRefPubMedPubMedCentral
2.
go back to reference Hokema A, Zoe Oliver B, Hoffstein V (2008) Predicting effective continuous positive airway pressure. Obstructive Sleep Apnea Ther 87(9):882–888 Hokema A, Zoe Oliver B, Hoffstein V (2008) Predicting effective continuous positive airway pressure. Obstructive Sleep Apnea Ther 87(9):882–888
3.
go back to reference Gilmartin GS, Daly RW, Thomas RJ (2005) Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med 11:485–493CrossRefPubMed Gilmartin GS, Daly RW, Thomas RJ (2005) Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med 11:485–493CrossRefPubMed
4.
go back to reference White DP (2005) Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 172(11):1363–1370CrossRefPubMed White DP (2005) Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 172(11):1363–1370CrossRefPubMed
5.
go back to reference Wellman A, Jordan AS, Malhotra A, Fogel RB, Katz ES, Schory K, Edwards JK, White DP (2004) Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 170(11):1225–1232CrossRefPubMed Wellman A, Jordan AS, Malhotra A, Fogel RB, Katz ES, Schory K, Edwards JK, White DP (2004) Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 170(11):1225–1232CrossRefPubMed
6.
go back to reference Younes M, Ostrowski M, Thompson W, Leslie C, Shewchuk W (2001) Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 163(5):1181–1190CrossRefPubMed Younes M, Ostrowski M, Thompson W, Leslie C, Shewchuk W (2001) Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 163(5):1181–1190CrossRefPubMed
7.
8.
go back to reference Thomas RJ, Terzano MG, Parrino L, Weiss JW (2004) Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern—a recognizable polysomnographic variant with practical clinical implications. Sleep 27(2):229–234CrossRefPubMed Thomas RJ, Terzano MG, Parrino L, Weiss JW (2004) Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern—a recognizable polysomnographic variant with practical clinical implications. Sleep 27(2):229–234CrossRefPubMed
9.
go back to reference Thomas R (2011) The chemoreflex and sleep-disordered breathing: man and machine vs. the beast. Sleep Med 12:533–535CrossRefPubMed Thomas R (2011) The chemoreflex and sleep-disordered breathing: man and machine vs. the beast. Sleep Med 12:533–535CrossRefPubMed
10.
go back to reference Janssens JP, Adler D, Pasquina P, Contal O (2016) Contribution of back-up respiratory rate setting in noninvasive ventilation. InNoninvasive Mechanical Ventilation 2016. Springer International Publishing, pp 673–680 Janssens JP, Adler D, Pasquina P, Contal O (2016) Contribution of back-up respiratory rate setting in noninvasive ventilation. InNoninvasive Mechanical Ventilation 2016. Springer International Publishing, pp 673–680
11.
go back to reference Aurora RN, Bista SR, Casey KR, Chowdhuri S, Kristo DA, Mallea JM, Ramar K, Rowley JA, Zak RS, Heald JL (2016) Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline: “The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses”. J Clin Sleep Med 12(5):757–761CrossRefPubMedPubMedCentral Aurora RN, Bista SR, Casey KR, Chowdhuri S, Kristo DA, Mallea JM, Ramar K, Rowley JA, Zak RS, Heald JL (2016) Updated adaptive servo-ventilation recommendations for the 2012 AASM guideline: “The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses”. J Clin Sleep Med 12(5):757–761CrossRefPubMedPubMedCentral
12.
go back to reference Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA (2008) Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 4(2):157–171PubMed Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA (2008) Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 4(2):157–171PubMed
13.
go back to reference Randerath WJ, Galetke W, Stieglitz S, Laumanns C, Schäfer T (2008) Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne–Stokes respiration. Sleep Med 9(8):823–830CrossRefPubMed Randerath WJ, Galetke W, Stieglitz S, Laumanns C, Schäfer T (2008) Adaptive servo-ventilation in patients with coexisting obstructive sleep apnoea/hypopnoea and Cheyne–Stokes respiration. Sleep Med 9(8):823–830CrossRefPubMed
14.
go back to reference Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A (2013) Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 188(8):996–1004CrossRefPubMedPubMedCentral Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A (2013) Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 188(8):996–1004CrossRefPubMedPubMedCentral
15.
go back to reference Ballester E, Badia JR, Hernandez L et al (1999) Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med 159:495–501CrossRefPubMed Ballester E, Badia JR, Hernandez L et al (1999) Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnoea/hypopnea syndrome. Am J Respir Crit Care Med 159:495–501CrossRefPubMed
16.
go back to reference Farre R, Hernandez L, Montserrat JM, Rotger M, Ballester E, Navajas D (1999) Sham continuous positive airway pressure for placebo controlled studies in sleep apnoea. Lancet 353:1154CrossRefPubMed Farre R, Hernandez L, Montserrat JM, Rotger M, Ballester E, Navajas D (1999) Sham continuous positive airway pressure for placebo controlled studies in sleep apnoea. Lancet 353:1154CrossRefPubMed
17.
go back to reference Karlawish JH, Pack AI (2001) Addressing the ethical problems of randomized and placebo-controlled trials of CPAP. Am J Respir Crit Care Med 163:809–810CrossRefPubMed Karlawish JH, Pack AI (2001) Addressing the ethical problems of randomized and placebo-controlled trials of CPAP. Am J Respir Crit Care Med 163:809–810CrossRefPubMed
18.
go back to reference Ward S, Chatwin M, Heather S, Simonds AK (2005) Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60(12):1019–1024CrossRefPubMedPubMedCentral Ward S, Chatwin M, Heather S, Simonds AK (2005) Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60(12):1019–1024CrossRefPubMedPubMedCentral
19.
go back to reference Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, Kristo DA, Mallea JM, Rowley JA, Zak RS, Tracy SL (2012) The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35(1):17–40CrossRefPubMedPubMedCentral Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, Kristo DA, Mallea JM, Rowley JA, Zak RS, Tracy SL (2012) The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35(1):17–40CrossRefPubMedPubMedCentral
20.
go back to reference Mulgrew AT, Al Lawati N, Ayas NT, Fox N, Hamilton P, Cortes L, Ryan CF (2010) Residual sleep apnea on polysomnography after 3 months of CPAP therapy: clinical implications, predictors and patterns. Sleep Med 11(2):119–125CrossRefPubMed Mulgrew AT, Al Lawati N, Ayas NT, Fox N, Hamilton P, Cortes L, Ryan CF (2010) Residual sleep apnea on polysomnography after 3 months of CPAP therapy: clinical implications, predictors and patterns. Sleep Med 11(2):119–125CrossRefPubMed
Metadata
Title
Polysomnographic determinants of requirement for advanced positive pressure therapeutic options for obstructive sleep apnea
Publication date
01-05-2018
Published in
Sleep and Breathing / Issue 2/2018
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-017-1556-8

Other articles of this Issue 2/2018

Sleep and Breathing 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.